During the past decade, Clinica Internacional; Unidad De Investigacion conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinica Internacional; Unidad De Investigacion" are "Alzheimer Disease" (2 trials), "Alzheimer's Disease" (1 trials), "Multiple Sclerosis" (1 trials) and "Multiple Sclerosis, Primary Progressive" (1 trials). Many other conditions were trialed in "Clinica Internacional; Unidad De Investigacion" in a lesser frequency.

Most popular intervention types in "Clinica Internacional; Unidad De Investigacion" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Gantenerumab" (2 trials), "Ocrelizumab" (2 trials), "Placebo" (2 trials), "Antihistamine" (1 trials) and "Crenezumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica Internacional; Unidad De Investigacion" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Clinica Internacional; Unidad De Investigacion". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Clinica Internacional; Unidad De Investigacion, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Clinica Internacional; Unidad De Investigacion, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".